PITTSBURGH, July 3, 2025 /PRNewswire/ — “I thought there could be a better way to carry and heat food, especially to work, school, while traveling, commuting, or while enjoying outdoor activities,” said an inventor, from Lake City, Fla., “so I invented the HEATED COOLER. My design enables you to easily heat foods in minutes, and […]

NORRIS, Tenn., July 3, 2025 /PRNewswire/ — As the United States prepares to commemorate 250 years of independence in 2026, communities across the Tennessee River Valley are shining a light on the role the Appalachian frontier played in the birth of the nation—and how small towns continue to carry that legacy through July 4th traditions

PITTSBURGH, July 3, 2025 /PRNewswire/ — “I thought there could be an improved way for HVAC workers to move the compressor portion of a condenser unit,” said an inventor, from Jacksonville, Fla., “so I invented the COMPRESSOR HOIST. My design would eliminate the physical labor typically involved in this process.” The patent-pending invention provides an

LOS ANGELES, July 3, 2025 /PRNewswire/ — The Law Offices of Frank R. Cruz announces that investors with losses related to Vestis Corporation (“Vestis” or the “Company”) (NYSE: VSTS) have opportunity to lead the securities fraud class action lawsuit. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN VESTIS CORPORATION (VSTS), CLICK HERE BEFORE AUGUST 8,

“Exploring the Dynamic Growth and Regulatory Evolution of the Global Medical Device Industry: A Comprehensive Analysis of Market Trends, Technological Advancements, and Emerging Opportunities in the Post-COVID-19 Era” BOSTON, July 3, 2025 /PRNewswire/ — BCC Research announces the release of its “2024 Medical Devices Research Review,” which provides insights into the rapidly growing global market

LOS ANGELES, July 3, 2025 /PRNewswire/ — The Law Offices of Frank R. Cruz announces that investors with losses related to Rocket Pharmaceuticals, Inc. (“Rocket” or the “Company”) (NASDAQ: RCKT) have opportunity to lead the securities fraud class action lawsuit. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ROCKET PHARMACEUTICALS, INC. (RCKT), CLICK HERE BEFORE